US Patent 7001915 Ultrashort-acting opioids for transdermal applications
Patent 7001915 was granted and assigned to Aryx Therapeutics on February, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 14 Nov, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Article (+445 characters)
Article
Patent abstract
The subject invention encompasses compounds of the formula: wherein R1, R2, and R3 are as defined herein. The subject invention also concerns methods for synthesizing the compounds of the invention. The invention also concerns compositions comprising the above compounds as well as methods for treating pain in a patient, where the method comprises administering a compound of the invention to a patient in need of such treatment.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Pascal Druzgala0
Date of Patent
February 21, 2006
0Patent Application Number
107714830
Date Filed
February 2, 2004
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 7001915 Ultrashort-acting opioids for transdermal applications
Find more entities like US Patent 7001915 Ultrashort-acting opioids for transdermal applications
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.